Minnesota 2023-2024 Regular Session

Minnesota House Bill HF1915

Introduced
2/16/23  

Caption

Pharmacists authorized to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use, or treatment of COVID-19.

Impact

If passed, HF1915 would amend several provisions of Minnesota Statutes, specifically sections related to the pharmacy practice. It would provide a framework for pharmacists to engage in certain medical functions traditionally reserved for physicians, such as prescribing medication. This change is expected to ease the burden on healthcare systems during public health emergencies by allowing quicker access to treatments and potentially alleviating some of the pressure on primary care providers.

Summary

House File 1915 proposes to authorize pharmacists in Minnesota to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis, postexposure prophylaxis, and treatment of COVID-19. The bill aims to enhance the role of pharmacists in managing public health, particularly in the context of the ongoing pandemic, by allowing them to provide necessary medications directly to patients under specific conditions. This measure is particularly significant as it seeks to expand access to important treatments while ensuring that they are used appropriately and safely.

Contention

There is notable contention surrounding the bill, particularly regarding the controversial nature of the drugs in question—hydroxychloroquine and ivermectin. Both have been subjects of widespread debate regarding their efficacy and safety for COVID-19 treatment. Opponents of the bill may express concerns over pharmacists having the authority to prescribe such medications without a physician's direct involvement, fearing potential misuse or mismanagement of these drugs. Supporters, however, argue that allowing pharmacists this authority could improve healthcare delivery and patient outcomes during public health crises.

Companion Bills

MN SF1643

Similar To Pharmacist authorization to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use or the treatment of COVID-19

Previously Filed As

MN SF1643

Pharmacist authorization to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use or the treatment of COVID-19

MN SB339

HIV preexposure prophylaxis and postexposure prophylaxis.

MN SB159

HIV: preexposure and postexposure prophylaxis.

MN HB1007

To Authorize Pharmacists To Dispense Hiv Preexposure And Postexposure Prophylaxis.

MN SB195

Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions; provide

MN SF2320

Pharmacists authorization to prescribe, dispense and administer drugs to prevent the acquisition of human immunodeficiency virus

MN HF2466

Pharmacists authorized to prescribe, dispense, and administer drugs to prevent acquisition of human immunodeficiency virus; pharmacists authorized to order, conduct, and interpret laboratory tests necessary for therapy that uses drugs to prevent acquisition of human immunodeficiency virus.

MN SF1176

Licensed pharmacists authority to initiate, order and administer vaccines and certain medical and laboratory tests; coverage under medical assistance requirement

MN HF1197

Licensed pharmacist authority expanded to initiate, order, and administer vaccines and medical and laboratory tests; and medical assistance coverage required.

MN HB579

Provides relative to pharmacist authorization to dispense HIV pre-exposure and post-exposure prophylaxis

Similar Bills

MN SF1643

Pharmacist authorization to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use or the treatment of COVID-19

WV HB4309

Relating to the use of certain drugs to treat Covid-19

TX SB301

Relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.

VA SB711

Prescriptions; off-label use.

CO HB1015

Off-label Use Of Approved Drugs To Treat COVID-19

MO SB1242

Modifies provisions relating to certain COVID-19 medications

MN SF2898

Ivermectin and hydroxychloroquine made available without a prescription by all pharmacies requirement

SC H3916

Ivermectin and Hydroxychloroquine